reglab/housing_qa huggingface dataset:
HI Rev Stat § 325-2 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-2 Physicians, laboratory directors, and health care professionals to report.

  §325-2 Physicians, laboratory directors, and health care professionals to report. Every physician or health care professional having a client affected by or suspected of being affected by a disease or condition declared to be communicable or dangerous to the public health by the director of health shall report the incidence or suspected incidence of such disease or condition to the department of health in writing or in the manner specified by the department of health. Every laboratory director having laboratory data regarding an individual affected by or suspected of being affected by a disease or condition declared to be communicable or dangerous to the public health shall report such diseases or conditions to the department of health in writing or in a manner specified by the health department; provided that the laboratory data reported to the department of health shall include the individual's complete demographic information, including name, date of birth, residential address, and phone number, obtained and confirmed at the time of specimen collection for the purposes of facilitating a public health investigation as necessary by the department of health. Every physician, laboratory director, or health care professional who violates this section may be fined in an amount not to exceed $1,000 per violation, to be assessed by the director of health. The director of health is authorized to impose the penalty pursuant to this section. [PC 1869, c 59, §24; am L 1911, c 125, §1; am L 1919, c 22, §1; RL 1925, §932, pt of §1022; RL 1935, §1090; am L 1943, c 43, §5(b); RL 1945, §2301; am L 1949, c 53, §29; RL 1955, §49-2; am L Sp 1959 2d, c 1, §19; HRS §325-2; gen ch 1985; am L 1987, c 265, §2; am L 1988, c 158, §1; am L 2016, c 115, §2]
HI Rev Stat § 325-2.5 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-2.5 Health care-associated infection reporting.

 §325-2.5 Health care-associated infection reporting. (a) Each health care facility in the State that is certified by the Centers for Medicare and Medicaid Services shall report information about health care-associated infections to the Centers for Disease Control and Prevention's national healthcare safety network, as specified in the rules of the Centers for Medicare and Medicaid Services.  (b) Health care facilities subject to this section shall authorize the Centers for Disease Control and Prevention to allow the department to access health care-associated infection data reported by those health care facilities to the national healthcare safety network.  (c) The department may adopt rules pursuant to chapter 91 to require that health care-associated infections that are multidrug-resistant be reported to the department through the national healthcare safety network. The rules shall specify which health care facilities are required to report those health care-associated infections that are multidrug-resistant through the national healthcare safety network, as well as the patient populations that are to be targeted in the reports. The first year of reporting required under this subsection shall be a pilot test of the reporting system and shall not be reported or disclosed to the public.  (d) The department shall preserve patient confidentiality and shall not disclose to the public any patient-level data obtained from any health care facility.  (e) The department may issue reports to the public regarding health care-associated infections in aggregate data form to protect individual patient identity. The reports may identify individual health care facilities. The reports shall use the methodology or any part of the methodology developed by the Centers for Disease Control and Prevention and the Centers for Medicare and Medicaid Services for national reporting of health care-associated infections.  (f) Health care-associated infection information held by the department as a result of reporting under this section is not subject to subpoena, discovery, or introduction into evidence in any civil or criminal proceeding; provided that health care-associated infection information otherwise available from other sources is not immune from subpoena, discovery, or introduction into evidence through those sources solely because the information was reported as required by this section.  (g) Beginning on June 30, 2013, and no later than June 30 of each year, thereafter, the department shall prepare a public report, in accordance with this section, containing information pertaining to health care-associated infections in the State for the previous calendar year.  (h) For the purposes of this section:  "Department" means the department of health.  "Health care facility" means the same as in section 323D-2. [L 2011, c 177, §2] Revision Note  Section was enacted as an addition to chapter 321 but was renumbered to this chapter pursuant to §23G-15.
HI Rev Stat § 325-3 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-3 Others to report.

 §325-3 Others to report. The director of health shall have the authority to determine which other persons shall report to the department of health communicable diseases or conditions dangerous to the public health. The director of health may assess an administrative fine not to exceed $1,000 per violation against persons who refuse or neglect to report immediately such diseases or conditions to the department of health. Persons assessed an administrative fine under this section shall not be subject to other sanctions provided by this chapter. [PC 1869, c 59, §25; am L 1911, c 125, §2; RL 1925, §933; RL 1935, §1091; RL 1945, §2302; RL 1955, §49-3; am L Sp 1959 2d, c 1, §19; HRS §325-3; am L 1987, c 265, §3]
HI Rev Stat § 325-4 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-4 Identity of patients safeguarded.

 §325-4 Identity of patients safeguarded. Reports to the department of health provided for by this chapter shall not be made public so as to disclose the identity of the persons to whom they relate except as necessary to safeguard the public health against those who disobey the rules relating to these diseases or to secure conformity to the laws of the State.  Reports to the department of health of persons who had or have diseases or conditions transmittable by blood or blood products may be disclosed by the department to any blood bank to enable it to reject as donors those individuals, any law to the contrary notwithstanding. In addition, the department may disclose to any blood bank information on persons suspected by physical symptoms, clinical examination, or laboratory evidence of having diseases or conditions transmittable by blood or blood products, any law to the contrary notwithstanding. [L 1927, c 117, §1; RL 1935, §1092; RL 1945, §2303; RL 1955, §49-4; am L Sp 1959 2d, c 1, §19; HRS §325-4; am L 1973, c 6, §1; am L 1987, c 264, §1]
HI Rev Stat § 325-5 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-5 Antitoxins, antiserums, vaccines, biologics, and drugs.

 §325-5 Antitoxins, antiserums, vaccines, biologics, and drugs. The department of health shall purchase from time to time out of moneys which may be available to it therefor, and keep on hand and available for administration under this section in the several counties to persons unable to pay for them, antitoxins, antiserums, vaccines, and other biologics and drugs of types and in a supply sufficient for the public health, welfare, and safety.  The antitoxins, antiserums, vaccines, biologics, and drugs shall by any physician of the department or of any such county be administered free of charge to any person who is in need of them and is unable to pay for them or shall be furnished free of charge to the attending physician of the person for use in the treatment of the person; provided that the person so benefited, or the person's estate, or personal representatives, if subsequently able to do so, may be required by the department to pay for any such antitoxin, antiserum, vaccine, biologic, or drug furnished free of charge to or for the person under this chapter. [L 1931, c 197, §1; RL 1945, §2305; am L 1945, c 191, §1; RL 1955, §49-5; am L Sp 1959 2d, c 1, §19; HRS §325-5; gen ch 1985]
HI Rev Stat § 325-6 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-6 Epidemic control.

 §325-6 Epidemic control. Such appropriations as may be necessary for the purpose of controlling, suppressing, or preventing the spread of any communicable or preventable disease in the State or in any county thereof shall be allocated by the legislature out of the proceeds of the state general fund. The department shall include in its budgetary request for each upcoming fiscal period, the amounts necessary to effectuate the purposes of this section.  Whenever the department of health certifies that any communicable or preventable disease is present to such an extent that the usual facilities and personnel of the department are not adequate to properly control, suppress, or prevent the spread of the disease, expenditures may be made by the department, with the approval of the governor, for use, in whatever manner the department may deem necessary, in controlling, suppressing, or preventing the spread of any such disease. [L 1941, c 121, § §1, 2; am L 1943, c 43, §2; RL 1945, §2306; RL 1955, §49-6; am L 1957, c 152, §1; am L Sp 1959 2d, c 1, §19; HRS §325-6; am L 1993, c 280, §35]
HI Rev Stat § 325-7 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-7 REPEALED.

  §325-7 REPEALED. L 1996, c 211, §7.
HI Rev Stat § 325-9 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-9 Quarantine without removal; duty of police officers to assist in removals and enforcement of quarantine.

 §325-9 Quarantine without removal; duty of police officers to assist in removals and enforcement of quarantine. If the department of health or its agent determines that the removal of the person infected or suspected of being infected would directly and seriously aggravate the disease so as to endanger the person's life, the department, or its agent may make provision for the person, as directed in section 325-8, in the house in which the person may be; and, in such case, the department or its agent may cause the persons in the neighborhood to be removed, and may take such other measures as it judges necessary for the public health and safety. The department or its agent, in effecting any removal or quarantine under this section or section 325-8, may require any sheriff, deputy sheriff, chief of police, or police officer to aid and assist it, and such force as is reasonably necessary to effect any such removal or quarantine may be used.  Every sheriff, deputy sheriff, chief of police, or police officer who is so required to aid and assist the department or its agent shall immediately aid and assist it. [PC 1869, c 59, §27; RL 1935, §1096; am L 1941, c 262, §2; RL 1945, §2308; RL 1955, §49-9; am L Sp 1959 2d, c 1, §19; HRS §325-9; gen ch 1985; am L 1989, c 211, §10; am L 1990, c 281, §11; am L 2005, c 29, §1; am L 2006, c 38, §8]
HI Rev Stat § 325-10 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-10 REPEALED.

  §325-10 REPEALED. L 1996, c 211, §8.
HI Rev Stat § 325-11 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-11 REPEALED.

 §325-11 REPEALED. L 1988, c 140, §1.
HI Rev Stat § 325-12 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-12 Common drinking cup prohibited.

 §325-12 Common drinking cup prohibited. The use of a common drinking cup is prohibited in all public places within the State. [L 1911, c 118, §4; RL 1925, §941; RL 1935, §1101; RL 1945, §2319; RL 1955, §49-12; HRS §325-12]
HI Rev Stat § 325-13 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-13 Rules.

  §325-13 Rules. (a) For the purpose of carrying out this chapter, the director of health, with the approval of the governor, may adopt, amend, or repeal such rules as the director deems necessary which, when adopted in accordance with chapter 91, shall have the force and effect of law.  (b) The rules shall be designed to:  (1) Protect the health and safety of the public;  (2) Establish appropriate levels of access to Hawaii immunization registry information by authorized users;  (3) Establish data entry and reporting requirements for health care providers; and  (4) Establish penalties for the failure to comply with any rule. [L 1911, c 118, §17; RL 1925, §954; RL 1935, §1114; RL 1945, §2341; RL 1955, §49-13; am L 1965, c 96, §35; HRS §325-13; gen ch 1985; am L 2010, c 113, §2]
HI Rev Stat § 325-14 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-14 Penalty.

 §325-14 Penalty. Any person violating this chapter, or any rule or regulation of the department of health relating thereto, shall be deemed guilty of a misdemeanor. Except as herein otherwise provided the punishment therefor shall be the same as provided by section 321-18. [L 1911, c 118, §16; RL 1925, §953; RL 1935, §1113; am L 1943, c 43, §5(b)(2); RL 1945, §2342; RL 1955, §49-14; HRS §325-14]
HI Rev Stat § 325-15 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-15 REPEALED.

  §325-15 REPEALED. L 2017, c 79, §2.
HI Rev Stat § 325-17 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-17 Quality assurance standards for HIV antibody testing.

 §325-17 Quality assurance standards for HIV antibody testing. (a) All laboratories performing screening and diagnostic tests for the presence of the antibody to HIV (human immunodeficiency virus) shall follow the recommended protocols as set forth below. Any test used for other than experimental purposes shall be approved by the Food and Drug Administration (FDA) of the United States for the use to which it is put. Any initially reactive FDA-approved screening test must be confirmed by a second test of the same type. Any specimen yielding reactive results to both FDA-approved screening tests must have a supplemental test performed such as a Western Blot, an IFA (immunofluorescence assay), or an antigen detection assay; provided that these standards may be superseded by rules adopted by the department pursuant to chapter 91.  (b) Any laboratory performing tests for the presence of HIV may be required by the department of health to refer a sample from any specimen yielding a reactive result to the department for the purpose of supplemental testing of some or all samples for quality assurance purposes. The department may specify the information which shall accompany the specimen for epidemiological purposes; provided that the information shall not include any personal identifiers.  (c) The penalty for any violation of this section shall be as specified in section 325-14. [L 1988, c 165, §2; am L 1997, c 217, §4]
HI Rev Stat § 325-18 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-18 Advisory committees for health care workers infected with blood-borne infections.

  §325-18 Advisory committees for health care workers infected with blood-borne infections. (a) The director of health may appoint ad hoc advisory committees as needed to provide advice and recommendations to health care workers infected with HIV, HBV, or other blood-borne infections on the risks of blood-borne disease transmission through exposure-prone invasive procedures. An advisory committee may recommend changes in a health care worker's practice, including patient notification, to reduce the possibility of transmission to patients. Each committee shall include:  (1) An infectious disease specialist with expertise appropriate to the case; and  (2) A professional peer of the infected health care worker, who has expertise in the professional practice performed by that worker. The committee may also include the health care worker's personal physician and, if the worker's practice is facility-based, members of the facility's infection control committee. The department of health shall provide oversight and necessary staff support to the advisory committees when resources permit.  (b) An advisory committee shall serve only as long as necessary for the particular case or cases for which the committee is appointed, but its members may be named to subsequent committees as needed. Members of advisory committees shall serve without compensation, but shall be reimbursed for travel expenses as necessary by the department of health for the performance of their duties.  (c) Notwithstanding any law to the contrary, work of the advisory committees, including records, shall be confidential, except that a summary of non-identifying information and general policy recommendations may be made available to the public. All committee meetings shall be closed to the public. [L 1994, c 265, §2]
HI Rev Stat § 325-19 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-19 Rubella testing of pregnant women.

  §325-19 Rubella testing of pregnant women. Every person permitted by law to attend a pregnant woman in the State, during the period of gestation or at delivery, shall cause a blood specimen from that woman to be tested for immunity to rubella, except when the woman does not consent or there is documentation that the woman has been tested previously for immunity to rubella or has been immunized against rubella. [L 1995, c 153, §1]
HI Rev Stat § 325-20 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-20 Agreements; collaborative assistance in control of disease outbreaks.

  §325-20 Agreements; collaborative assistance in control of disease outbreaks. (a) The director may enter into agreements for collaborative assistance with licensed health care facilities and health care providers in the State to control an epidemic of a dangerous disease, which requires more physical facilities, materials, or personnel than the department has available.  (b) Whenever used in this section, unless a different meaning clearly appears from the context:  "Dangerous disease" means any illness or health condition that might pose a substantial risk of a significant number of human fatalities or incidents of permanent or long-term disability.  "Department" means the department of health.  "Director" means the director of health.  "Epidemic" means the occurrence of cases of an illness clearly in excess of normal expectancy, as determined by the director.  "Health care facility" means a facility as defined in section 323D-2.  "Health care provider" means a provider as defined in section 323D-2.  (c) Under collaborative agreements, health care facilities or health care providers shall provide prophylactic and treatment services for the epidemic disease in collaboration with and under the general direction of the department and shall seek reimbursement from the individuals who receive medical care, the parties responsible for their care, or their health plans. Persons having health plan benefits shall be responsible for any copayments to the facilities or health care providers.  (d) The agreements may provide that the department shall use reasonable efforts to seek legislative appropriations to reimburse health care facilities and health care providers for the use of physical facilities, professional services, and materials provided to persons without health plan coverage.  (e) Except in cases of wilful misconduct, the following persons shall not be liable for the death of or injury to any person who is provided care pursuant to this section or for damage to property when resulting from any act or omission in the performance of such services:  (1) The State or any political subdivision;  (2) A health care facility or health care provider acting at the direction of the department under an agreement as provided in this section; and  (3) Persons engaged in disease prevention and control functions pursuant to this section or sections 325-8 and 325-9, including volunteers whose services are accepted by any authorized person. [L 2002, c 169, §2]
HI Rev Stat § 325-21 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-21 Sale of sterile syringes for the prevention of disease.

  §325-21 Sale of sterile syringes for the prevention of disease. (a) The sale of sterile hypodermic syringes in a pharmacy, physician's office, or health care institution for the purpose of preventing the transmission of dangerous blood-borne diseases, may be made solely by:  (1) A pharmacist licensed under chapter 461;  (2) A physician as defined in section 327E-2;  (3) A health care provider as defined in section 327E-2; or  (4) An authorized agent of a pharmacy, as defined in section 461-1, or of a health care institution, as defined in section 327E-2, operating under the direction of a licensed pharmacist or physician.  (b) The seller under subsection (a) shall provide the purchaser written educational material approved by the department of health under subsection (e) about prevention of blood-borne diseases, drug treatment, and safe disposal of used syringes at sites where syringes are sold.  (c) The sale or purchase of sterile hypodermic syringes under subsection (a) shall not constitute an offense under section 329-43.5.  (d) Nothing in this section provides immunity from prosecution to any person who violates any law that prohibits or regulates the use, possession, dispensing, distribution, or promotion of controlled substances, dangerous drugs, detrimental drugs, or harmful drugs, including but not limited to violation of section 329-41, 329-42, or 712-1241 to 712-1249.6.   (e) The department of health shall produce and make available to pharmacies, physicians' offices, and health care institutions written educational material about prevention of blood-borne diseases, drug treatment, and safe disposal of used syringes for distribution under subsection (b).  (f) For purposes of this section, "sell" or "sale" means to transfer to another for value or consideration. [L 2001, c 292, §1; am L 2004, c 151, §2] Cross References  Needle exchange program, see § §325-111 to 117.
HI Rev Stat § 325-31 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|325. Infectious and Communicable Diseases|325-31 REPEALED.

  §325-31 REPEALED. L 1974, c 6, §1.